Cancer Cachexia Clinical and Research Integration Program (CaXI)

Our team of basic and clinical researchers will work together to better understand the molecular mechanisms of cancer cachexia, develop new methods for earlier-detection and improve clinical treatments

Cancer cachexia is a cancer-induced wasting syndrome which affects 30% of all cancer patients and 80% of patients with advanced cancers.

It is different from malnutrition as it cannot be reversed by increasing calorie intake. As it progresses, patients with cancer cachexia experience reduced quality of life and physical performance, and lower response to and tolerance of cancer treatments.

This initiative - the Cancer CacheXia Clinic and Research Integration Program (CaXI) - aims to increase understanding of cancer cachexia and improve outcomes for patients.

Our team of basic and clinical researchers will work together to better understand the molecular mechanisms of cancer cachexia, develop new methods for earlier-detection and improve clinical treatments.

Resources

News

Meet the team

Contact

E: This email address is being protected from spambots. You need JavaScript enabled to view it.